Zidovudine, Lamivudine and Nevirapine Tablet

Get a Price/Quote

MOQ : 500 Boxes

Zidovudine, Lamivudine and Nevirapine Tablet Specification

Purity
98% (API Content)

Application
Antiviral, HIV Treatment

Molecular Formula
C10H13N5O4 (Zidovudine), C8H11N3O3S (Lamivudine), C15H15N5O2 (Nevirapine)

CAS No
30516-87-1 (Zidovudine), 134678-17-4 (Lamivudine), 129618-40-2 (Nevirapine)

Grade
Pharmaceutical Grade

Formulations Type
General Drugs

Formulations Form
Tablets

Treatments & Functions
Management of HIV-1 infection

Gender/Age Group
Suitable for Adults

Dosage Guidelines
As directed by physician

Storage Instructions
Dry Place

Zidovudine, Lamivudine and Nevirapine Tablet Trade Information

Minimum Order Quantity
500 Boxes

FOB Port
Mundra Port

Payment Terms
Letter of Credit (L/C), Paypal, Western Union, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
10000 Boxes Box Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Buyer Requirements

Main Export Market(s)
Australia, North America, South America, Eastern Europe, Middle East, Africa, Western Europe, Central America, Asia

Main Domestic Market
All India

Certifications
ISO, GMP, WHO, FDA

About Zidovudine, Lamivudine and Nevirapine Tablet

Zidovudine, Lamivudine and Nevirapine Tablet

Product Description
Considered as one of the reliable companies in pharmaceutical industry, we are successfully exporting a wide stock of Zidovudine-Lamivudine And Nevirapine Tab. Zidovudine-Lamivudine And Nevirapine Tab is indicated for the treatment of human immunodeficiency virus type 1 infection. Before procuring the entire stock of Zidovudine-Lamivudine And Nevirapine Tab from renowned vendors.

Key points:

The medicine belongs to a specific class of medications called reverse transcriptase inhibitors
Recommended for adults and children weighing 25 kg or more

Specifications:

Brand: Duovir-N
Contain: Zidovudine-Lamivudine & Nevirapine Tab
company: Cipla
Packing: 30 Tab Bottle

Comprehensive HIV-1 Treatment

Triomune combines three potent antiretroviral agentsZidovudine, Lamivudine, and Nevirapinewithin one convenient tablet. This formulation supports effective and continuous management of HIV-1 infection by inhibiting viral replication at different stages of the viruss life cycle. The film-coated tablets are developed for optimal patient adherence and are suitable for adult use under medical supervision.

Strict Quality Standards and Approvals

Triomune is produced in facilities certified by WHO GMP and ISO standards, ensuring stringent manufacturing protocols. The product holds necessary regulatory approvalsUSFDA, WHO Prequalification, and relevant local authoritiesguaranteeing safety, purity, and consistent therapeutic outcomes. Each batch undergoes rigorous testing for pharmaceutical grade quality and API content.

Safe Storage and Administration

This medication is provided in secure blister packs or HDPE bottles, maintaining drug integrity and hygiene. The tablets must be stored in a dry place and consumed as prescribed by a healthcare provider. Adhering to storage and dosage instructions maximizes product efficacy and minimizes the risk of side effects or reduced potency.

FAQs of Zidovudine, Lamivudine and Nevirapine Tablet:

Q: How should Triomune or its equivalent be administered?

A: Triomune tablets should be taken orally as prescribed by your healthcare provider. Follow your physicians dosage directions closely, and do not stop or adjust the dose without consulting your doctor. Swallow each tablet whole with water, and take it consistently at the same times each day to maintain effective drug levels.

Q: What are the primary benefits of using Triomune for HIV treatment?

A: Triomune offers the advantage of combining Zidovudine, Lamivudine, and Nevirapine in a single tablet, which helps control HIV-1 infection by reducing viral replication. This simplifies treatment regimens, improves adherence, and enhances patient outcomes by decreasing viral load and supporting immune system function.

Q: When should I contact my doctor while using Triomune?

A: Contact your doctor immediately if you experience signs of hypersensitivity (such as rash, severe fatigue, or trouble breathing), severe side effects like persistent nausea, anemia, or abnormal tiredness. Regular check-ups are important for ongoing monitoring of your health and drug effects during therapy.

Q: Where should Triomune be stored for maximal shelf life?

A: Keep Triomune tablets in their original packagingeither blister or HDPE bottleand store them in a cool, dry place away from direct sunlight and moisture. Always keep the medication out of reach of children and do not use beyond the expiry date printed on the packaging.

Q: What are the common side effects associated with Triomune tablets?

A: Common side effects may include nausea, headache, fatigue, and occasionally anemia. Serious reactions are rare but require immediate medical attention. Always monitor your health and inform your physician of any new or worsening symptoms during the course of your treatment.

Q: Who should not use Triomune or equivalent formulations?

A: Triomune is contraindicated in patients with known hypersensitivity to Zidovudine, Lamivudine, Nevirapine, or any tablet components. Inform your physician about all allergies and medical history before starting therapy to ensure suitability and safety.

Tell us about your requirement